Vertex Pharmaceuticals (VRTX) Tax Rate (2011 - 2026)

Vertex Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 17.68% for Q1 2026.

• On a quarterly basis, Tax Rate rose 616.0% year-over-year to 17.68% in Q1 2026; TTM through Mar 2026 was 16.02%, a 24543.0% increase from a year earlier, with the FY2025 full-year figure at 14.86%, down 30067.0% from the prior year.
• Tax Rate improved to 17.68% in Q1 2026 per VRTX's latest filing, from 10.51% in the prior quarter.
• Across five years, Tax Rate topped out at 23.95% in Q4 2022 and bottomed at 5.97% in Q2 2024.
• The 5-year median for Tax Rate is 17.68% (2026), against an average of 16.15%.
• Across the five-year window, Tax Rate sank 23070 bps in 2022 and jumped 2546 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 23.95% in 2022, then slumped by 35 bps to 15.58% in 2023, then advanced by 26 bps to 19.67% in 2024, then tumbled by 47 bps to 10.51% in 2025, then jumped by 68 bps to 17.68% in 2026.
• Per Business Quant, the three latest VRTX Tax Rate figures stand at 17.68% (Q1 2026), 10.51% (Q4 2025), and 16.62% (Q3 2025).